Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 29 points (0.2%) at 17,603 as of Monday, Nov. 10, 2014, 12:00 PM ET. The NYSE advances/declines ratio sits at 1,659 issues advancing vs. 1,296 declining with 183 unchanged. The Services sector currently sits up 0.2% versus the S&P 500, which is up 0.3%. Top gainers within the sector include Norfolk Southern ( NSC), up 2.9%, CSX ( CSX), up 2.4%, Melco Crown Entertainment ( MPEL), up 2.2%, Target ( TGT), up 2.0% and CBS ( CBS), up 1.9%. On the negative front, top decliners within the sector include Time Warner Cable ( TWC), down 3.6%, and Visa ( V), down 0.8%. TheStreet would like to highlight 3 stocks pushing the sector higher today: 3. CVS Health ( CVS) is one of the companies pushing the Services sector higher today. As of noon trading, CVS Health is up $0.57 (0.6%) to $88.95 on light volume. Thus far, 1.3 million shares of CVS Health exchanged hands as compared to its average daily volume of 4.2 million shares. The stock has ranged in price between $87.92-$89.04 after having opened the day at $88.11 as compared to the previous trading day's close of $88.38. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more. CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services in the United States. The company operates through Pharmacy Services and Retail Pharmacy segments. CVS Health has a market cap of $101.4 billion and is part of the health services industry. Shares are up 23.5% year-to-date as of the close of trading on Friday. Currently there are 17 analysts who rate CVS Health a buy, no analysts rate it a sell, and 3 rate it a hold. TheStreet Ratings rates CVS Health as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full CVS Health Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.